Market Performance
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) surged 5.1% in today's trading, closing at $1.34.
The Healthcare stock traded 1,322,961.3821 shares, below its average daily volume of 1,986,296 shares.
big mover upAMEX:LCTX
Lineage Cell Therapeutics, Inc. (LCTX) Surges 5.1% on Heavy Volume
Market Performance Lineage Cell Therapeutics, Inc. (AMEX:LCTX) surged 5.1% in today's trading, closing at $1.34. The Healthcare stock traded 1,322,961.3821 shares, below its…
Company Overview
Lineage Cell Therapeutics, Inc. has a market capitalization of $396.8M. The stock has traded year-to-date.
Sharp single-day moves like this rally in Lineage Cell Therapeutics, Inc. are often driven by news catalysts — earnings surprises, analyst actions, sector developments, or broader market conditions. Investors should identify the specific driver before making trading decisions, as the sustainability of the move depends on whether the catalyst changes the fundamental outlook.
Lineage Cell Therapeutics, Inc. currently trades at $1.34, positioning the stock at the 24th percentile of its 52-week range ($1.18 — $1.86). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View LCTX Stock Page
Frequently Asked Questions
What is causing LCTX's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our LCTX news page.
What is LCTX's 52-week range?
See full price history and interactive charts on our LCTX chart page.